Drugs & medicalClass III

Zydus Pharmaceuticals (USA) Inc recalls Estradiol Transdermal System, USP (Twice-Weekly) 0.025mg/day, Rx Only, Manufactured by: Cadila Healthcare Limited, Ahmedabad,…

Failed Impurities/Degradation Specifications.

Read the official notice →
Date
2024-06-12
Country
United States
Brand
Zydus Pharmaceuticals
Product
Estradiol Transdermal System, USP (Twice-Weekly) 0.025mg/day, Rx Only, Manufactured by: Cadila Healthcare Limited, Ahmedabad, India,…
Classification
Class III
Units
Nationwide within the United States
Category
Drugs & medical
Source
FDA · Drug

Copied automatically from the US Food and Drug Administration. Details may be shortened or out of date; the official notice is the authoritative source. Disclaimer

What to do

  1. Check the product name, strength and lot number against the official notice.
  2. Do not stop a prescribed medicine without talking to your doctor or pharmacist first.
  3. Ask the pharmacy or supplier about a replacement or refund.

General guidance from Recall Atlas. The official notice from the US Food and Drug Administration has the exact models, batch codes and remedy, and it takes priority.

More Zydus Pharmaceuticals recalls

  1. 2024-07-24
  2. US
  3. 2024-07-17
  4. US
    Drugs & medicalClass III

    Zydus Pharmaceuticals (USA) Inc recalls Micafungin for injection, USP, 100 mg/vial, Single-Dose Vial, Rx Only, Manufactured by: Zydus Lifesciences Ltd., Vadodara, India,…

    Cross contamination with other products

    FDA · DrugZydus Pharmaceuticals (USA) IncNationwide in the USA and Puerto RicoOfficial notice →
  5. US
    Drugs & medicalClass III

    Zydus Pharmaceuticals (USA) Inc recalls Verapamil Hydrochloride Injection, USP 5 mg / 2mL(2.5 mg/mL), packaged as (a) 25x2 mL Single-Dose Vial per carton, Vial NDC:…

    Cross contamination with other products.

    FDA · DrugZydus Pharmaceuticals (USA) IncNationwide in the USAOfficial notice →
  6. 2023-11-15
  7. US
    Drugs & medicalClass II

    Zydus Pharmaceuticals (USA) Inc recalls Oxybutynin Chloride Extended-Release Tablet USP, 5 mg, 100 count bottles, Rx Only, Manufactured by: Cadila Healthcare Ltd,…

    Failed Dissolution Specifications-out-of-specification (OOS) test results observed for dissolution at the 6 month long term time point.

    FDA · DrugZydus Pharmaceuticals (USA) IncNationwide.Official notice →
  8. 2023-10-11
  9. US
  10. 2023-03-22
  11. US
    Drugs & medicalClass III

    Zydus Pharmaceuticals (USA) Inc recalls Colchicine Tablets, USP 0.6 mg, Rx Only, a) 30 tablets per bottle, NDC 16714-0039-01, b) 100 tablets per bottle, NDC…

    Failed Impurities/Degradation Specifications: An out-of-specification (OOS) result was observed during release testing of one lot for a related substance, i.e. Beta-lumicolchicine.

    FDA · DrugZydus Pharmaceuticals (USA) IncAZ, OH, MS.Official notice →
All 26 Zydus Pharmaceuticals recalls →

Other drugs & medical recalls in the United States

  1. 2024-06-12
  2. US
    Drugs & medicalClass I

    ARROW INTERNATIONAL Inc. recalls Arrow FiberOptix Intra-Aortic Balloon Catheter Kit: a) REF IAB-05830-LWS; b) REF IAB-05840-LWS; c) REF IAB-05850-LWS

    Teleflex received reports indicating an infrequent condition that, when not identified and corrected promptly, could result in serious health consequences. The issue may manifest as: -failure of the intra-aortic…

    FDA · DeviceARROW INTERNATIONAL Inc.Worldwide distribution. US nationwide including Puerto Rico, AU, BA, BE, BG,…Official notice →
  3. US
    Drugs & medicalClass I

    Getinge Usa Sales Inc recalls Vaporizer Sevoflurane Maquet Filling, Product code/REF number (6682282), Component of: Flow-i C20, Flow-i C30,Flow-i C40, Flow-c, Flow-e.

    Sevoflurane used with the vaporizer may degrade to hydrogen fluoride, which could present a risk to patients or health care providers through inhalation and/or skin exposure. Potential harms include irritation of…

    FDA · DeviceGetinge Usa Sales IncDomestic: CA, CO, IN, MO, OR, VA, WA. International: Aruba, Australia,…Official notice →
  4. US
    Drugs & medicalClass III

    GlaxoSmithKline LLC recalls Tivicay PD (dolutegravir) 5mg Tablets for Oral Suspension, 60-count bottles, Each carton contains one bottle of 60 tablets, one 30-mL…

    Labeling: Incorrect Lot and/or Expiration Date: The carton has incorrect expiration of 2026-MAY*, whereas the correct expiration date, which is on the tablet bottle label, is 2025-APR.

    FDA · DrugGlaxoSmithKline LLCNationwide within the United StatesOfficial notice →
  5. US
    Drugs & medicalClass III

    Rising Pharma Holding, Inc. recalls Pregabalin Capsules 50mg, 1000-count bottle, Rx Only, Manufactured for: Rising Pharma Holdings, Inc., East Brunswick, NJ 08816,…

    Presence of Foreign Tablets/Capsules: Complaint received from a re-packager, American Health Packaging (AHP), where a foreign tablet was discovered in one of the bottles during packaging set up. Tablet identified as…

    FDA · DrugRising Pharma Holding, Inc.Nationwide in the USAOfficial notice →
  6. US
    Drugs & medicalClass III

    Bryant Ranch Prepack, Inc. recalls Cephalexin for Oral Suspension, USP, 250mg per 5mL, Rx only, 100mL (when mixed), Each contains cephalexin monohydrate, USP equivalent…

    Labeling: Not Elsewhere Classified: Back Label states Each contains: cephalexin monohydrate, USP equivalent to 5g' on the back label instead of Each Bottle contains: cephalexin monohydrate, USP equivalent to 5g'

    FDA · DrugBryant Ranch Prepack, Inc.Nationwide in the USAOfficial notice →
  7. US
    Drugs & medicalClass III

    Bryant Ranch Prepack, Inc. recalls Cephalexin for Oral Suspension, USP, 250mg/ 5mL, Rx only, 200mL (when mixed), Each contains cephalexin monohydrate, USP equivalent to…

    Labeling: Not Elsewhere Classified: Back Label states 'Each contains: cephalexin monohydrate, USP equivalent to 5g' instead of Each Bottle contains: cephalexin monohydrate, USP equivalent to 10g'

    FDA · DrugBryant Ranch Prepack, Inc.Nationwide in the USAOfficial notice →
See all drugs & medical recalls →